A randomized controlled trial of exercise in spinal and bulbar muscular atrophy

Annals of Clinical and Translational Neurology

Volumn 2, Issue 7, 2015, Pages 739-747

  Shrader, Joseph A ^a   Kats, Ilona ^b   Kokkinis, Angela ^b   Zampieri, Cris ^a   Levy, Ellen ^a   Joe, Galen O ^a   Woolstenhulme, Joshua G ^a   Drinkard, Bart E ^a   Smith, Michaele R ^a   Ching, Willie ^a   Ghosh, Laboni ^b   Fox, Derrick ^b   Auh, Sungyoung ^b   Schindler, Alice B ^b   Fischbeck, Kenneth H ^b   Grunseich, Christopher ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; SOMATOMEDIN C;

ACCELEROMETRY; ADOLESCENT; ADULT; ADULT MYOPATHY ASSESSMENT TOOL; AEROBIC EXERCISE; ARTICLE; CONTROLLED STUDY; ENDURANCE TRAINING; EXERCISE INTENSITY; EXERCISE TEST; FEMALE; FUNCTIONAL STATUS; HUMAN; HUMAN EXPERIMENT; KENNEDY DISEASE; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCULOSKELETAL DISEASE ASSESSMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE MUSCLE ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIT TO STAND TEST; TIMED UP AND GO TEST;

EID: 84946481353     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.208     Document Type: Article

References (32)

1. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968;18:671–680.
2. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77–79.
3. Orr CR, Montie HL, Liu Y, et al. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem 2010;285:35567–35577.
4. Lieberman AP, Yu Z, Murray S, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 2014;7:774–784.
5. Harris-Love MO, Fernandez-Rhodes L, Joe G, et al. Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool. Rehabil Res Pract 2014;2014:873872.
6. Takeuchi Y, Katsuno M, Banno H, et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008;8:964–971.
7. Thiebaud RS, Funk MD, Abe T. Home-based resistance training for older adults: a systematic review. Geriatr Gerontol Int 2014;14:750–757.
8. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993;74:711–715.
9. Krivickas L. Exercise in neuromuscular disease. J Clin Neuromuscul Dis 2003;5:29–39.
10. Bang P, Brandt J, Degerblad M, et al. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest 1990;20:285–292.
11. Schwarz AJ, Brasel JA, Hintz RL, et al. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996;81:3492–3497.
12. Palazzolo I, Stack C, Kong L, et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 2009;63:316–328.
13. Cup EH, Pieterse AJ, Broek-Pastoor T, et al. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil 2007;88:1452–1464.
14. Voet NB, van der Kooi EL, Riphagen II, et al. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2010;1:1–40.
15. Abresch RT, Carter GT, Han JJ, McDonald CM. Exercise in neuromuscular diseases. Phys Med Rehabil Clin N Am 2012;23:653–673.
16. Nelson ME, Layne JE, Bernstein MJ, et al. The effects of multidimensional home-based exercise on functional performance in elderly people. J Gerontol A Biol Sci Med Sci 2004;59:154–160.
17. Bello-Haas VD, Florence JM, Kloos AD, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007;68:2003–2007.
18. Preisler N, Andersen G, Thøgersen F, et al. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). Neurology 2009;72:317–323.
19. Robertson RJ, Goss FL, Rutkowski J, et al. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc 2003;35:333–341.
20. Robertson RJ, Goss FL, Dube J, et al. Validation of the adult OMNI scale of perceived exertion for cycle ergometer exercise. Med Sci Sports Exerc 2004;36:102–108.
21. Rhodes LE, Freeman BK, Auh S, et al. Clinical features of spinal and bulbar muscular atrophy. Brain 2009;132:3242–3251.
22. American Congress of Rehabilitation Medicine and the American Academy of Physical and Medicine and Rehabilitation. Muscular weakness assessment: use of normal isometric strength data. Arch Phys Med Rehabil 1996;77:1251–1255.
23. Stoll T, Huber E, Seifert B, et al. Maximal isometric muscle strength: normative values and gender-specific relation to age. Clin Rheumatol 2000;19:105–113.
24. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther 1996;76:248–259.
25. Schenkman M, Riley PO, Pieper C. Sit to stand from progressively lower seat heights – alterations in angular velocity. Clin Biomech 1996;11:153–158.
26. Heil DP. Predicting activity energy expenditure using the Actical activity monitor. Res Q Exerc Sport 2006;77:64–80.
27. Esliger DW, Probert A, Connor Gorber S, et al. Validity of the Actical accelerometer step-count function. Med Sci Sports Exerc 2007;39:1200–1204.
28. Kayes NM, Schluter PJ, McPherson KM, et al. Exploring Actical accelerometers as an objective measure of physical activity in people with multiple sclerosis. Arch Phys Med Rehabil 2009;90:594–601.
29. Fernández-Rhodes LE, Kokkinis AD, White MJ, et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 2011;10:140–147.
30. Kenney K, Landau ME, Gonzalez RS, et al. Serum creatine kinase after exercise: drawing the line between physiological response and exertional rhabdomyolysis. Muscle Nerve 2012;45:356–362.
31. Paschalis V, Koutedakis Y, Jamurtas AZ, et al. Equal volumes of high and low intensity of eccentric exercise in relation to muscle damage and performance. J Strength Cond Res 2005;19:184–188.
32. Hashizume A, Katsuno M, Banno H, et al. A functional scale for spinal and bulbar muscular atrophy: cross-sectional and longitudinal study. Neuromuscul Disord 2015. Epub ahead of print.